Association for Accessible Medicines filed 2 comments on this docket between Jun 5, 2026 and Jun 5, 2026. 2 other organizations filed here. The comment window closed 15d ago.
FDA, Please find attached comments from the Association for Accessible Medicines (AAM) regarding Docket No. FDA-2026-N-0809 "Recommendations on Scale-Up and Postapproval Changes Guidances for Industry" Thanks, Scott Kuzner, Ph.D., Senior Director, Sciences and Regulatory Affairs, AAM
FDA, Please find attached comments from the Association for Accessible Medicines (AAM) regarding Docket No. FDA-2026-N-0809 "Recommendations on Scale-Up and Postapproval Changes Guidances for Industry" Thanks, Scott Kuzner, Ph.D., Senior Director, Sciences and Regulatory Affairs, AAM
No abstract recorded.
View on regulations.gov →